Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of GLR1075 Injection Following Single and Multiple Dosing in Healthy Trial Participants and Multiple Dosing in Cirrhotic Trial Participants With and Hypoalbuminemia

NCT07851688 is registered in ClinicalTrials.gov with Gan & Lee Pharmaceuticals. as lead sponsor.

NCT NCT07851688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07851688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of GLR1075 Injection Following Single and Multiple Dosing in Healthy Trial Participants and Multiple Dosing in Cirrhotic Trial Participants With and Hypoalbuminemia
Lead sponsor
Gan & Lee Pharmaceuticals.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 7, 2026
Completion date
December 31, 2028
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoalbuminemia in cirrhotic ascites